The densities of NMDA and GABA receptors on platelets were investigated using immunocytochemical methods.Results: Patients with BD presented higher serum levels of NMDA-R antibodies in comparison to healthy individuals (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: Glutamatergic/GABAergic imbalance due to autoimmune antibodies targeting N-methyl-D-aspartate receptors (NMDA-R) is considered to be one of the shared pathways between bipolar disorder (BD) and autoimmune diseases.
📊
Key Findings & Data:We aimed to assess serum concentrations of NMDA-R antibodies and density of NMDA and GABA receptors on platelets in euthymic patients with BD in comparison to healthy individuals; and to determine the impact of sex on serum concentrations of NMDA-R antibodies and the density of NMDA and GABA receptors on platelets.Method: NMDA antibody IgG were detected in serum samples of 27 DSM IV euthymic patients with bipolar disorder (16 females, 11 males) and 33 healthy individuals (17 females, 16 males), using ELISA method.
💡
Conclusion & Impact:The densities of NMDA and GABA receptors on platelets were investigated using immunocytochemical methods.Results: Patients with BD presented higher serum levels of NMDA-R antibodies in comparison to healthy individuals (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objective: Glutamatergic/GABAergic imbalance due to autoimmune antibodies targeting N-methyl-D-aspartate receptors (NMDA-R) is considered to be one of the shared pathways between bipolar disorder (BD) and autoimmune diseases. Evidence shows female vulnerability to autoimmune disorders, and suggests a sex-specific approach in autoimmunity research in BD. We aimed to assess serum concentrations of NMDA-R antibodies and density of NMDA and GABA receptors on platelets in euthymic patients with BD in comparison to healthy individuals; and to determine the impact of sex on serum concentrations of NMDA-R antibodies and the density of NMDA and GABA receptors on platelets.Method: NMDA antibody IgG were detected in serum samples of 27 DSM IV euthymic patients with bipolar disorder (16 females, 11 males) and 33 healthy individuals (17 females, 16 males), using ELISA method. The densities of NMDA and GABA receptors on platelets were investigated using immunocytochemical methods.Results: Patients with BD presented higher serum levels of NMDA-R antibodies in comparison to healthy individuals (p
🔖
Cite This Article
DOYURAN, K., CAN, G., CEYLAN, D., ÖZERDEM, A., ERŞEN, A., MISIR, E., AKAN, P. (2022). Increased serum levels of NMDA receptor antibodies in female patients with bipolar disorder. Klinik Psikiyatri Dergisi, Cilt: 22 - Sayı: 2, 125–138. https://ajindex.com/articles/573857
Sylvia LG, Shelton RC, Kemp DE, Bernstein EE, Friedman ES, Brody BD, McElroy SL, Singh V, Tohen M, Bowden CL, Ketter TA, Deckersbach T, Thase ME, Reilly-Harrington NA, Nierenberg AA, Rabideau DJ, Kinrys G, Kocsis JH, Bobo WV, Kamali M, McInnis MG, Calabrese JR. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar Disord 2015;17:212-23
Perugi G, Quaranta G, Belletti S, Casalini F, Mosti N, Toni C, Dell'Osso L. General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases. J Affect Disord 2015;170:95-103
SayuriYamagata A, Brietzke E, Rosenblat JD, Kakar R, McIntyre RS. Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems. J Affect Disord 2017;211:99-106. 4.Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord 2010;12:638-46
Wang LY, Chiang JH, Chen SF, Shen YC. Systemic autoimmune diseases are associated with an increased risk of bipolar disorder: A nationwide population-based cohort study. J Affect Disord 2017;227:31-7
Cremaschi L, Kardell M, Johansson V, Isgren A, Sellgren CM, Altamura AC, Hultman CM, Landén M.Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls. Psychiatry Res 2017;258:9-14
Barbuti M, Carvalho AF, Köhler CA, Murru A, Verdolini N, Guiso G, Samalin L, Maes M, Stubbs B, Perugi G, Vieta E, Pacchiarotti I. Thyroid autoimmunity in bipolar disorder: A systematic review. J Affect Disord 2017;221:97-106
Tiosano S, Nir Z, Gendelman O, Comaneshter D, Amital H, Cohen AD, Amital D. The association between systemic lupus erythematosus and bipolar disorder - a big data analysis. Eur Psychiatry 2017;43:116-9
Popescu A, H. Kao A. Neuropsychiatric Systemic Lupus Erythematosus. Curr Neuropharmacol 2011;9:449-57
Spinosa MJ, Bandeira M, Liberalesso PB, Vieira SC, Janz LL Jr, Sá EG, Löhr A Jr. Clinical, laboratory and neuroimage findings in juvenile systemic lupus erythematosus presenting involvement of the nervous system. Arq Neuropsiquiatr 2007;65:433-9
Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A, Leung S, Patten SB; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis. Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology 2015;85:1972-9